StockNews.AI
BON
StockNews.AI
152 days

BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent Launch

1. BON announced a new patented postbiotic ingredient for blood sugar control. 2. The product reduces post-meal glucose spikes by 15-30% after eating. 3. Early data shows it outperforms existing market leaders. 4. The company plans global patent protection for long-term growth. 5. BON aims to capture significant market share in metabolic health.

5m saved
Insight
Article

FAQ

Why Bullish?

The announcement of a superior product indicates potential strong revenue growth, similar to past product launches that drove investor interest, such as in the biotech sector.

How important is it?

The strategic patenting and product efficacy are likely to attract investor confidence, affecting BON’s market perception positively.

Why Long Term?

The patent strategy and expected market entry could influence BON's stock over several quarters, akin to other firms in the health industry that saw continued stock growth post-patent approval.

Related Companies

KDPCRBPMNKD
March 20, 2025 09:00 ET  | Source: Bon Natural Life Limited XI’AN, China, March 20, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar is gearing up for release. The Company has engineered a food-derived postbiotic formula for glycemic management, slated to hit shelves in the near term. When taken 10-30 minutes before meals, this breakthrough product delivers targeted control over post-meal glucose spikes, cutting blood sugar surges by 15-30% within the critical 1-3 hour window after eating-proven through rigorous testing. Early data shows its efficacy not only rivals but outperforms leading products already dominating the market. Beyond its precision, the formula boasts a unique edge: It’s food-safe, easy to use, and designed for seamless integration into daily routines-key factors driving high user adherence. With these advantages, the solution is poised to disrupt the post-meal blood sugar control sector and capture significant market share. Yongwei Hu, Chairman of the Company, said "Backed by a robust IP strategy, the Company is aggressively pursuing global patent protection. Over the next two years, we plan to lock down approvals across top markets, safeguarding our innovation while positioning ourselves for long-term dominance in the fast-growing metabolic health space. This strategic move not only shields the technology but also primes the business for scalable revenue growth and investor appeal." About Bon Natural Life Limited ("BON")BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit the Company’s website at http://www.bnlus.com. For more information, please contact: Cindy Liu | IR Email: bonnatural@appchem.cn Safe Harbor Statement This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Related News